ArticleScience China. Life sciences2025
3D facial imaging: a novel approach for metabolic abnormalities risk profiling.
Article in Science China. Life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Structural decomposition enables multi-omics dissection of common and organ-specific aging.Science China. Life sciences · 2026Article
- Interactive multimodal disease risk evaluation using a self-service non-invasive device.Communications medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human face harbors a rich tapestry of complex phenotypic information spanning genetic, environmental, and physiological dimensions. While facial images excel in diagnosing genetic diseases, their untapped potential for predicting metabolic health presents an intriguing prospect. Metabolic Syndrome (MetS), marked by a constellation of metabolic abnormalities, poses a significant risk for various chronic diseases. Utilizing Face-Wide Association Studies (FaWAS) on a discovery cohort of 2,621 Chinese individuals and a replication cohort of 2,188 Chinese individuals, we investigated the associations between facial features and MetS and its related conditions. Our findings highlight half of our investigated facial features strongly correlated with MetS risk, such as a slender forehead, a broader and shorter jawline, and fuller features around the temples-eye-cheek region, with notable genetic correlations (0.55-0.58) and influences from environmental factors like age, urban residency, and educational level. The developed face-based prediction model demonstrated significant predictive robustness, achieving an AUC of up to 0.87 for MetS and 0.89 for obesity in external validations, surpassing traditional 2D imaging techniques. Our model also aids in identifying subtypes within healthy populations, with a 2.07 to 2.40-fold increased risk of developing different metabolic disorders within the next five years. This paves the way for precise risk stratification of individuals who are "at risk". Integrating 3D facial imaging for metabolic health predictions, our research introduces an innovative, non-invasive framework for health assessment and subtype identification, demonstrating high potential in personalized medicine and health monitoring.
Indexed as
Identifiers
39976861What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.